Taro Aoki
16Patents
2h-index
22Co-inventors
50Inventor score
Filing activity: Feb 19, 2004 → Oct 2, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7022713B2 | Hyperlipemia therapeutic agent | Human Necessities | 113 | Expired |
| US7776881B2 | Hyperlipemia therapeutic agent | Human Necessities | 103 | Active |
| US7659271B2 | Pyrimidine compound having dibenzylamine structure and medicament comprising the same | Chemistry; Metallurgy | 2 | Active |
| US7459447B2 | Method for treating hyperlipidemia | Human Necessities | 2 | Active |
| US9488751B2 | Droplet oscillation device and droplet oscillation method | Physics | 1 | Active |
| US8685952B2 | Method for the treatment of diabetes | Human Necessities | 1 | Active |
| US7750019B2 | Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same | Human Necessities | 1 | Active |
| US7790737B2 | Substituted pyrimidine compounds and their utility as CETP inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8604054B2 | Triglyceride-lowering agent and hyperinsulinism-ameliorating agent | Chemistry; Metallurgy | 0 | Active |
| US11408804B2 | Pathological specimen preparation device and pathological specimen preparation system | Physics | 0 | Active |
| US10871499B2 | Reagent cartridge, reagent cartridge set, and pathological specimen preparation device | Performing Operations; Transporting | 0 | Active |
| US11680943B2 | Electric field stirring apparatus, electric field stirring method, and pathological sample manufacturing apparatus | Physics | 0 | Active |
| US7973053B2 | Nerve cell death inhibitor | Human Necessities | 0 | Active |
| US7598233B2 | Method for treating thrombosis | Human Necessities | 0 | Expired |
| US8012989B2 | Substituted pyrimidine compounds and their utility as CETP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8124622B2 | Triglyceride-lowering agent and hyperinsulinism-ameliorating agent | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.